These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10405826)

  • 1. Immunohistochemical detection of induced expression of wild-type p53 tumor suppressor protein in the livers of rats treated with diethylnitrosamine.
    Martens U; Stenius U
    Histochem J; 1999 Jan; 31(1):75-8. PubMed ID: 10405826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenobiotics modulate the p53 response to DNA damage in preneoplastic enzyme-altered foci in rat liver; effects of diethylnitrosamine and phenobarbital.
    Finnberg N; Stenius U; Högberg J
    Toxicol Sci; 2000 Mar; 54(1):95-103. PubMed ID: 10746936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type p53 expression in liver tissue and in enzyme-altered foci: an in vivo investigation on diethylnitrosamine-treated rats.
    Lennartsson P; Högberg J; Stenius U
    Carcinogenesis; 1998 Jul; 19(7):1231-7. PubMed ID: 9683182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression and TGF-alpha-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine.
    Lennartsson P; Stenius U; Högberg J
    Cell Biol Toxicol; 1999 Feb; 15(1):31-9. PubMed ID: 10195348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of preneoplastic rat liver lesions with an attenuated p53 response by low doses of diethylnitrosamine.
    Silins I; Stenius U; Högberg J
    Arch Toxicol; 2004 Sep; 78(9):540-8. PubMed ID: 15340777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents.
    Pääjärvi G; Viluksela M; Pohjanvirta R; Stenius U; Högberg J
    Carcinogenesis; 2005 Jan; 26(1):201-8. PubMed ID: 15459018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions.
    Finnberg N; Silins I; Stenius U; Högberg J
    Carcinogenesis; 2004 Jan; 25(1):113-22. PubMed ID: 14555611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical visualization of wild-type p53 protein in paraffin-embedded rat liver using tyramide amplification: zonal hepatic distribution of p53 protein after N-hydroxy-2-acetylaminofluorene administration.
    van Gijssel HE; van Gijlswijk RP; de Haas RR; Stark C; Mulder GJ; Meerman JH
    Carcinogenesis; 1998 Jan; 19(1):219-22. PubMed ID: 9472715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat.
    Silins I; Finnberg N; Ståhl A; Högberg J; Stenius U
    Carcinogenesis; 2001 Dec; 22(12):2023-31. PubMed ID: 11751435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion.
    van Gijssel HE; Maassen CB; Mulder GJ; Meerman JH
    Carcinogenesis; 1997 May; 18(5):1027-33. PubMed ID: 9163691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene expression in hepatocytes of the fish Rivulus ocellatus marmoratus during the necrotic and regenerative phases of diethylnitrosamine toxicity.
    Goodwin AE; Grizzle JM
    Carcinogenesis; 1994 Sep; 15(9):1985-92. PubMed ID: 7923594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 mutant protein(s) in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in male Fischer-344 rats.
    Smith ML; Yeleswarapu L; Locker J; Lombardi B
    Carcinogenesis; 1991 Jun; 12(6):1137-41. PubMed ID: 2044196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of p53 protein expression in preneoplastic rat hepatocytes in vitro after exposure to N-acetoxy-acetylaminofluorene, X-rays or a proteasome inhibitor.
    van Gijssel HE; Stenius U; Mulder GJ; Meerman JH
    Eur J Cancer; 2000 Jan; 36(1):106-12. PubMed ID: 10741303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant hepatic expression of the cell division control enzyme p34cdc2 kinase, proliferating cell nuclear antigen, p53 tumor suppressor protein, and p21Waf1 cyclin-dependent kinase inhibitory protein after WY14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) dosing to rats.
    Ma X; Stoffregen DA; Wheelock GD; Rininger JA; Babish JG
    Mol Pharmacol; 1997 Jan; 51(1):69-78. PubMed ID: 9016348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles.
    Tilly KI; Banerjee S; Banerjee PP; Tilly JL
    Endocrinology; 1995 Apr; 136(4):1394-402. PubMed ID: 7895650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.
    Finnberg N; Stenius U; Högberg J
    Cancer Lett; 2004 Apr; 207(2):149-55. PubMed ID: 15072823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential alteration of apoptosis, p53 expression, and cell proliferation in the rat pancreas treated with 4-hydroxyaminoquinoline 1-oxide.
    Imazawa T; Nishikawa A; Toyoda K; Furukawa F; Mitsui M; Hirose M
    Toxicol Pathol; 2003; 31(6):625-31. PubMed ID: 14585730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the expression of p53, c-myc, and bcl-2 oncoproteins in individual patient cultures of normal urothelium exposed to cobalt 60 gamma-rays and N-nitrosodiethanolamine.
    Harney JV; Seymour CB; Murphy DM; Mothersill C
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):617-25. PubMed ID: 8547828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.